Article Details

Kala Pharmaceuticals to Present Clinical Data for KPI-012, - GlobeNewswire

Retrieved on: 2022-05-01 13:09:05

Tags for this article:

Click the tags to see associated articles and topics

Kala Pharmaceuticals to Present Clinical Data for KPI-012, - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2022/05/01/2433063/0/en/Kala-Pharmaceuticals-to-Present-Clinical-Data-for-KPI-012-its-Mesenchymal-Stem-Cell-Secretome-Product-for-the-Treatment-of-PCED-at-the-2022-ARVO-Annual-Meeting.html

Excerpt

Data Demonstrate Rapid and Complete Wound Healing, with Six of Eight (75%) Patients Achieving Complete Healing within Four Weeks; All Remained Healed.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up